GOOSE portfolio company Saranas heads to clinical trials
Saranas Inc, a GOOSE portfolio company and Houston-based medical device startup, recently closed a round of $2.8 million to kick off clinical trails for their Early Bird Bleed Monitoring System. This round brings their total funding to $12 million.
Early Bird Bleed Monitoring System, invented by Dr. Mehdi Razavi at the Texas Heart Institute, is meant to detect bleeding complications during procedures. The company anticipates FDA approval in early 2019.
A big thank you to Houston Innovation Map and Business Wire for covering Saranas in full detail and the Texas Medical Center Innovation Institute for the support offered to Saranas and countless other healthcare startups.
GOOSE Capital is a Houston-based investment group comprised of ultra-high net worth, successful business executives and investors. GOOSE has invested over $55 million in early stage start-ups and has had numerous successful exits. The group invests around $10 million per year across a variety of industries, but with a focus on breakthrough, proprietary technologies.